KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Halozyme Therapeutics (HALO) over the last 16 years, with Q4 2025 value amounting to $118.2 million.

  • Halozyme Therapeutics' Prepaid Assets fell 113.51% to $118.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $118.2 million, marking a year-over-year decrease of 113.51%. This contributed to the annual value of $118.2 million for FY2025, which is 113.51% down from last year.
  • Halozyme Therapeutics' Prepaid Assets amounted to $118.2 million in Q4 2025, which was down 113.51% from $150.7 million recorded in Q3 2025.
  • In the past 5 years, Halozyme Therapeutics' Prepaid Assets registered a high of $150.7 million during Q3 2025, and its lowest value of $44.7 million during Q1 2021.
  • Moreover, its 5-year median value for Prepaid Assets was $69.5 million (2022), whereas its average is $82.3 million.
  • As far as peak fluctuations go, Halozyme Therapeutics' Prepaid Assets crashed by 2028.99% in 2023, and later soared by 8530.39% in 2024.
  • Halozyme Therapeutics' Prepaid Assets (Quarter) stood at $53.9 million in 2021, then surged by 32.34% to $71.3 million in 2022, then fell by 6.86% to $66.4 million in 2023, then soared by 79.96% to $119.5 million in 2024, then fell by 1.14% to $118.2 million in 2025.
  • Its last three reported values are $118.2 million in Q4 2025, $150.7 million for Q3 2025, and $133.0 million during Q2 2025.